Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S2.10
P/E—
Fwd P/E10.31
PEG0.58
52W— – —
RSI—
Target$107.57 (+15.1%)
Beta0.47
Div1.04%
Loading chart…
RSI ()
Loading patterns…
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 40
Overbought · 100
Signal
Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
8Bullish
5Bearish
0Neutral
Key Signals 4
▲ Double Bottom
Major reversal
2026-07-13 · $93.34
Two lows ~$84.75 — bullish reversal confirmed
Learn more →
▲ Inv. Head & Shoulders
Major reversal
2026-07-28 · $94.41
Inv. H&S neckline ~$94.41 broken — major bullish reversal
Learn more →
▼ Double Top
Major reversal
2026-07-01 · $85.78
Two peaks ~$91.80 — bearish reversal confirmed
Learn more →
▼ Double Top
Major reversal
2026-09-08 · $94.28
Two peaks ~$101.96 — bearish reversal confirmed
Learn more →
Momentum Signals 9
▲ MACD Bullish Crossover
▲ Bull Flag
▲ MACD Bullish Crossover
▲ Bull Flag
View overlays on the price chart via Overview tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
100%
8/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$107.57
+15.1% upside
Low $93
—
High $130
Consensus
Current price
Wall Street Analyst Ratings
Sort by
| Firm | Rating | Change | Action | Date |
|---|
Profitability
Gross Margin
69.88%Last 12 Months
Operating Margin
17.96%Last 12 Months
Return on Equity
6.41%Last 12 Months
Revenue Growth
4.80%Year over Year
Free Cash Flow
1.09BLast 12 Months
Free Cash Flow Yield
—Last 12 Months
Balance Sheet
Debt / Equity
60.17Most Recent Quarter
Current Ratio
1.69Most Recent Quarter
Cash
464.50MMost Recent Quarter
Total Debt
7.60BMost Recent Quarter
Net Debt
—Most Recent Quarter
How ZBH Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 17.83B |
| Enterprise Value | 24.98B |
| Trailing P/E | 22.42 |
| Forward P/E | 10.31 |
| PEG Ratio (5yr) | 0.58 |
| Price/Sales (ttm) | 2.10 |
| Price/Book (mrq) | 1.41 |
| EV/Revenue | 2.94 |
| EV/EBITDA | 9.78 |
Share Statistics
| Avg Vol (3m) | 2.21M |
| Shares Outstanding | 190.74M |
| Float | 190.12M |
| % Held by Insiders | 0.16% |
| % Held by Institutions | 111.36% |
| Short Ratio | 4.06 |
| Short % of Float | 6.08% |
Profitability
| Gross Margin | 69.88% |
| Operating Margin (ttm) | 17.96% |
| Profit Margin | 9.48% |
| Return on Assets (ttm) | 3.96% |
| Return on Equity (ttm) | 6.41% |
Income Statement
| Revenue (ttm) | 8.51B |
| Revenue Growth (yoy) | 4.80% |
| Gross Profit (ttm) | 5.95B |
| EBITDA | 2.56B |
| Net Income (ttm) | 806.70M |
| Diluted EPS (ttm) | 4.17 |
| EPS Growth (yoy) | 33.80% |
Balance Sheet
| Total Cash (mrq) | 464.50M |
| Total Debt (mrq) | 7.60B |
| Debt / Equity (mrq) | 60.17 |
| Current Ratio (mrq) | 1.69 |
| Book Value / Share | 66.23 |
| Operating CF (ttm) | 1.74B |
| Free Cash Flow (ttm) | 1.09B |
Trading & Dividends
| Beta (5Y) | 0.47 |
| 50-Day MA | 95.15 |
| 200-Day MA | 91.43 |
| Fwd Dividend Yield | 1.04% |
| Payout Ratio | 23.30% |
Income
Dividend Yield
1.04%Last 12 Months
Annual Rate
0.96Forward
Payout Ratio
23.30%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 23.30%
Monthly Dividends
Ownership Breakdown
Institutional 111.36%
Insider 0.16%
Short Interest
6.08% of float
Moderate
Institutional 13F Holdings
Famous investors who disclosed a position in ZBH in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Price | Value |
|---|